MedVasc AB
Our patented technology, Solutio catheter system enables pain-free & precise local anesthesia delivery, supporting an existing $1B market.
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location Lund, Sweden
- Currency USD
- Founded November 2013
- Employees 1
- Incorporation Type Other
- Website medvasc.se
Company Summary
MedVasc is a Swedish medical device company revolutionizing varicose vein treatment. Our patented technology, Solutio catheter system enables pain-free & precise local anesthesia delivery, supporting an existing $1B market.
De-risked Business Case
• Proof-of-concept, tested in humans
• Close to market (2026)
• FDA, PreSub and clear path to clearance
• Granted patents in all prioritized markets (Two patent families and one family of trademarks)
Team
-
>10 years of experience in leading roles
Senior in startup, business development, IP and innovation
B2B Startup x Corporate collaboration -
Founder, CMO & member of the board>30 years of experience in treating varicose veins
Owner of Scandinavian Venous Centre
Previous MedTech exit to Boston Scientific -
Advisor, Growth and Capital Strategy27 years of sales and marketing experience
Development and Implementation of Product and Business Strategy -
Eric WahlbergChair of the BoardProfessor Vascular Surgery
>20 years of experience as a life science executive
Investor and advisor -
Peter MarcussonBoard member- International sales of medial device
- M&A -
Head of Quality & Regulatory Affairs>8 years of experience from leading RA/QA roles
-
Mats NilssonBoard MemberLawyer & Partner at MAQS Advokatbyrå
Advisors
-
Janice HoganUnconfirmed
Previous Investors
-
Dr. Michael ÅkessonUnconfirmed
LU Ventures (Lund University)Unconfirmed -
Life Science Invest GammaUnconfirmed
Peter MarcussonUnconfirmed
Mats NilssonUnconfirmed -
Investmentbolaget Carta HumanaUnconfirmed
RevealUnconfirmed
MontefeltroUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.